Richard Bastiani - Net Worth and Insider Trading

Richard Bastiani Net Worth

The estimated net worth of Richard Bastiani is at least $4 Million dollars as of 2024-05-04. Richard Bastiani is the Director of Abaxis Inc and owns about 46,700 shares of Abaxis Inc (ABAX) stock worth over $4 Million. Details can be seen in Richard Bastiani's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard Bastiani has not made any transactions after 2017-02-02 and currently still holds the listed stock(s).

Transaction Summary of Richard Bastiani

To

Richard Bastiani Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard Bastiani owns 2 companies in total, including Armata Pharmaceuticals Inc (ARMP) , and Abaxis Inc (ABAX) .

Click here to see the complete history of Richard Bastiani’s form 4 insider trades.

Insider Ownership Summary of Richard Bastiani

Ticker Comapny Transaction Date Type of Owner
ARMP Armata Pharmaceuticals Inc 2019-05-09 director
ABAX Abaxis Inc 2018-07-31 director

Richard Bastiani Latest Holdings Summary

Richard Bastiani currently owns a total of 1 stock. Richard Bastiani owns 46,700 shares of Abaxis Inc (ABAX) as of February 2, 2017, with a value of $4 Million.

Latest Holdings of Richard Bastiani

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABAX Abaxis Inc 2017-02-02 46,700 83.00 3,876,100

Holding Weightings of Richard Bastiani


Richard Bastiani Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard Bastiani has made a total of 0 transactions in Abaxis Inc (ABAX) over the past 5 years. The most-recent trade in Abaxis Inc is the sale of 4,000 shares on February 2, 2017, which brought Richard Bastiani around $204,480.

Insider Trading History of Richard Bastiani

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard Bastiani Trading Performance

GuruFocus tracks the stock performance after each of Richard Bastiani's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard Bastiani is 27.78%. GuruFocus also compares Richard Bastiani's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard Bastiani within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Richard Bastiani's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Richard Bastiani

Average Return

Average return per transaction

Outperforming Transactions

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.69
Relative Return to S&P 500(%) 11.66

Richard Bastiani Ownership Network

Ownership Network List of Richard Bastiani

No Data

Ownership Network Relation of Richard Bastiani


Richard Bastiani Owned Company Details

What does Armata Pharmaceuticals Inc do?

Who are the key executives at Armata Pharmaceuticals Inc?

Richard Bastiani is the director of Armata Pharmaceuticals Inc. Other key executives at Armata Pharmaceuticals Inc include Corporate Controller and PFO Richard Rychlik , director & Chief Executive Officer Deborah Birx , and Chief Financial Officer Julianne Averill .

Armata Pharmaceuticals Inc (ARMP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Armata Pharmaceuticals Inc (ARMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Armata Pharmaceuticals Inc (ARMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Armata Pharmaceuticals Inc (ARMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Armata Pharmaceuticals Inc Insider Transactions

No Available Data

Richard Bastiani Mailing Address

Above is the net worth, insider trading, and ownership report for Richard Bastiani. You might contact Richard Bastiani via mailing address: C/o Abaxis Inc, 3240 Whipple Rd, Union City Ca 94587.

Discussions on Richard Bastiani

No discussions yet.